MCK Stock Overview
McKesson Corporation provides healthcare services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
McKesson Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$492.00 |
| 52 Week High | US$499.90 |
| 52 Week Low | US$319.00 |
| Beta | 0.45 |
| 1 Month Change | -0.40% |
| 3 Month Change | 9.09% |
| 1 Year Change | 52.32% |
| 3 Year Change | 202.40% |
| 5 Year Change | 376.10% |
| Change since IPO | 923.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCK | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.1% | 2.0% | -2.5% |
| 1Y | 52.3% | -3.8% | -0.4% |
Return vs Industry: MCK exceeded the German Healthcare industry which returned -3.8% over the past year.
Return vs Market: MCK exceeded the German Market which returned -0.4% over the past year.
Price Volatility
| MCK volatility | |
|---|---|
| MCK Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MCK has not had significant price volatility in the past 3 months.
Volatility Over Time: MCK's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
| MCK fundamental statistics | |
|---|---|
| Market cap | €64.93b |
| Earnings (TTM) | €2.82b |
| Revenue (TTM) | €283.26b |
22.7x
P/E Ratio0.2x
P/S RatioIs MCK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCK income statement (TTM) | |
|---|---|
| Revenue | US$301.51b |
| Cost of Revenue | US$289.33b |
| Gross Profit | US$12.18b |
| Other Expenses | US$9.18b |
| Earnings | US$3.00b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 22.81 |
| Gross Margin | 4.04% |
| Net Profit Margin | 0.99% |
| Debt/Equity Ratio | -338.3% |
How did MCK perform over the long term?
See historical performance and comparison